University of Queensland Secures Grant for Drug Development Research
Posted on: Tuesday, 11 April 2006, 12:00 CDT
In a deal set to boost Queensland's drug development capabilities, the Australian government has pledged to contribute towards a $1.73 million University of Queensland project to speed up medicines' entry to the market.
Anna Bligh, Queensland deputy premier, treasurer and minister for state development, trade and innovation, has announced a $865,000 grant for the University of Queensland's (UQ) Centre for Integrated Preclinical Drug Development, which conducts contract research via TetraQ.
The center will use the grant to develop new tools for a drug development toolkit. UQ and industry partners vivoPharm Pty, Industrial Research Limited and Ground Zero Pharmaceuticals will contribute funds to the total of $865,000.
Executive director of the center and TetraQ Professor Maree Smith said that the toolkit would help modernize and streamline the development pathway of new pharmaceuticals, addressing an acknowledged blockage in the drug production pipeline that is causing significant international concern.
"The number of new drugs reaching the market has fallen over the past five years. This is due to a lack of innovation in the pathway of preclinical trials, which are required before drugs move into human trials and then to the market," she said. "The center aims to develop new tools to streamline the preclinical trials process, which will be made available to biotechnology companies via TetraQ...This will improve productivity across the pharmaceuticals industry."
Source: Datamonitor
Related Articles
- Affitech-Discovered Anti-PS Antibodies in Development by Peregrine Pharmaceuticals Show Excellent Functionality in Preclinical Studies
- New Publication a Practical Guide to the Management of Chemical Process Development in the Pharmaceutical Industry
- New Report Gives Projections for the Pharmaceutical and Healthcare Market in Poland to 2009
- Health Canada Removes Cox-2 Drug Prexige From the Market Over Liver Problems
- YaSheng Group Receives Wide Support for Development of the California Asian Pacific Logistics Center
- Start-Up Elara Formed to Develop Anticancer Drugs
- NanoViricides Scheduled to Test Rabies Drug; Company on Course to Develop More Drugs Against Additional Diseases
- GEN ID Lab Services, Inc. To Develop New Drug Candidates to Stop Death in Humans From the Avian Flu Virus (''Bird Flu'')
- China Exclusive: China Develops AIDS Drug With Independent IPR
- The NCI-Funded Standardized Expression Measurement (SEM) Center(TM) Based on StaRT-PCR(TM) Enables Multi-Institutional Clinical Trials and Facilitates Development of Drugs and Molecular Diagnostic Tests
 |
 |
User Comments (0)
RSS Feeds